Garrison Capital Inc. Declares Second Quarter 2017

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
68
Garrison Capital Inc. Declares Second Quarter 2017 Distribution of $0.28 Per Share and Announces First Quarter 2017 Financial Results and Earnings Call

NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Garrison Capital Inc., a business development company (NASDAQ: GARS ), today announced its financial results for the first fiscal quarter ended March 31, 2017.

References to “we,” “us,” “our,” the “Company” and “Garrison Capital” refer to Garrison Capital Inc. and its consolidated subsidiaries.

First Quarter 2017 Highlights

  • Net investment income for the quarter ended March 31, 2017 was $4.2 million, or $0.26 per share;
  • Net realized gain on investments for the quarter ended March 31, 2017 was $0.2 million, or $0.01 per share;
  • Net change in unrealized loss from investments for the quarter ended March 31, 2017 was $8.4 million, or $0.51 per share;
  • Net decrease in net assets resulting from operations for the quarter ended March 31, 2017 was $4.0 million, or $0.24 per share; and
  • Our board of directors declared a second quarter 2017 distribution of $0.28 per share, payable on June 23, 2017 to stockholders of record as of June 9, 2017.

Consolidated Results of Operations

Consolidated operating results for the three months ended March 31, 2017 and December 31, 2016 are as follows:

  Three Months Ended   Three Months Ended
  March 31, 2017 December 31, 2016
($ in thousands, except per share data) (Unaudited) (Unaudited)
Net investment income $ 4,187   $ 4,933  
Total investment income   8,994     9,653  
Total net expenses   4,807     4,721  
Net realized gain/(loss) on investments   204     (999 )
Net change in unrealized loss on investments   (8,379 )   (1,080 )
Net decrease in net assets resulting from operations   (3,988 )   2,853  
     
Net investment income per share   0.26     0.31  
Net realized/unrealized loss from investments per share   (0.50 )   (0.13 )
Net loss per share   (0.24 )   (0.18 )
Net asset value per share   11.90     12.42  
             

Total investment income for the three months ended March 31, 2017 was $9.0 million and net investment income was $4.2 million. Total net expenses for the three months ended March 31, 2017 were $4.8 million.

The net realized gain on investments for the three months ended March 31, 2017 was primarily driven by $0.4 million of gains from the partial and full repayments of portfolio investments. This was offset by $0.2 million in realized losses in the GLC Trust 2013-2’s consumer loan portfolio.

The net change in unrealized loss for the three months ended March 31, 2017 was driven primarily by $9.0 million of negative credit related adjustments from Walnut Hill Physicians Hospital, Speed Commerce Operating Company, Forest Park Medical Center at San Antonio and Badlands Production Company investments in the amounts of $3.4 million, $3.3 million, $1.2 million and $1.1 million, respectively. This was offset by an aggregate $0.6 million of positive fair value adjustments across various portfolio investments.

Portfolio and Investment Activities

For the three months ended March 31, 2017, we purchased eight investments and closed add-on investments for a total increase to par in our portfolio of $28.6 million with a weighted average yield of 7.1%. For the three months ended March 31, 2017, repayments in our portfolio consisted of the paydowns of three investments, and other partial repayments for a total of $38.6 million of par with a weighted average yield of 10.6%.

See below for portfolio activity table.

                   
Par ($ in millions) Q1 2016   Q2 2016   Q3 2016   Q4 2016   Q1 2017       Average  
                   
Originated $ 8.2   $ 16.6   $ 18.5   $ -   $ -       $ 8.7    
Club   6.8     -     12.9     -     -         3.9    
Purchased   17.6     -     5.0     15.7     25.7         12.8    
Total add-on investments   3.4     5.1     2.6     2.9     2.9         3.4    
Total Additions   36.0       21.7        39.0       18.6       28.6           28.8    
Less: Total Repayments/Sales (1)(2)      (36.3 )     (21.2 )     (38.8 )       (42.8 )     (38.6 )         (35.5 )  
                   
Net Repayments/Additions $   (0.3 ) $   0.5   $   0.2   $   (24.2 ) $   (10.0 )     $   (6.7 )  
                   
                   
                   
Summary Q1 2016 (3)   Q2 2016   Q3 2016   Q4 2016   Q1 2017       Average  
Number of new investments   3     2     5     2     8         4    
Weighted average yield of additions (3)   10.5 %   9.6 %   10.8 %   8.0 %   7.1 %       9.2 %  
Number of repayments/sales (1)(2)   5     2     3     7     3         4    
Weighted average yield of repayments/sales (4)   8.1 %   9.0 %   10.2 %   11.5 %   10.6 %       9.9 %  
                   
                   

(1) There was one position restructure in Q2 2016 resulting in a reduction in par of $11.6 million. (2) Excludes the Q3 2016 BFN Operations LLC realization event and reduction of par of $11.8 million. (3) Q1 2016 activity excludes $16.0 million of transitory loans across five portfolio companies that were both purchased and sold during the quarter. Excludes non-accrual portfolio companies. (4) Weighted average yield excludes non-accrual portfolio companies.

The following table shows select information of our portfolio as of March 31, 2017 and December 31, 2016.

Summary of Portfolio characteristics ($ in millions)* March 31, 2017   December 31, 2016  
Total market value $ 358.7   $ 376.7  
Number of portfolio companies   61     57  
Average investment size (1) $ 5.7   $ 6.2  
Weighted average yield (2)   10.8 %   10.9 %
Weighted average price (1)   92.9     95.0  
First lien   97.1 %   96.6 %
Second lien & Mezzanine   - %   - %
Consumer loans   1.3 %   1.8 %
Equity & other   1.6 %   1.6 %
Core   93.5 %   97.3 %
Transitory   6.5 %   2.7 %
Originated (3)   52.6 %   53.0 %
Club (4)   18.8 %   27.0 %
Purchased   28.6 %   20.0 %
Floating (1)   98.9 %   96.8 %
Fixed (1)   1.1 %   3.2 %
Performing (1)   97.1 %   97.5 %
Non-accrual (1)   2.9 %   2.5 %
Weighted average debt/EBITDA (1)(2)(5)   3.7 x   3.6 x
Weighted average risk rating (1)   2.60     2.49  
             

(1) Excludes consumer loans and equity investments. (2) Excludes investments with a risk rating of 4, unfunded revolvers and equity investments. (3) Originated positions include investments where we have sourced and led the execution of the deal. (4) Club positions include investments where we provide direct lending to a borrower with one or two other lenders but did not lead the deal. (5) Excludes non-operating portfolio companies, which we define as those investments collateralized by real estate, proved developed producing value (“PDP”) or other hard assets. PDPs are proven revenues that can be produced with existing wells. As of March 31, 2017, $47.7 million of par value and $28.5 million of market value related to non-operating portfolio companies was excluded. As of December 31, 2016, $49.6 million of par value and $36.0 million of market value related to non-operating portfolio companies was excluded. * Table excludes positions with a fair value of zero.

Liquidity and Capital Resources

As of March 31, 2017, we had cash of $19.6 million and restricted cash of $14.6 million.

In addition to proceeds from public and private offerings of our debt and equity securities and the proceeds from portfolio repayments, we have identified eight portfolio companies with a total par value of $23.2 million and a fair value of $22.9 million which we view as transitory investments. Transitory investments are generally those investments that we view as an additional source of liquidity that we are able to sell in order to fund investments that fit our core investment strategy. These transitory investments are generally at the lower end of our target portfolio yield range.

Subject to leverage and borrowing base restrictions, as of March 31, 2017, we had $20.8 million available for additional borrowings under our senior secured revolving notes, $33.0 million of available SBIC leverage and no available borrowings under the GLC Trust 2013-2 Revolver.

Distributions

On May 2, 2017, our board of directors approved a distribution in the amount of $4.5 million, or $0.28 a share, which will be paid on June 23, 2017 to stockholders of record as of June 9, 2017.

Distributions are paid from taxable earnings and may include return of capital and/or capital gains. The specific tax characteristics of the distributions will be reported to stockholders on Form 1099-DIV after the end of the calendar year and in our periodic reports filed with the Securities and Exchange Commission.

Management and Incentive Fees

On May 3, 2017, the Company entered into the fourth amended and restated investment advisory agreement (the “Fourth Amended and Restated Investment Advisory Agreement”) with the Investment Adviser following approval of the agreement by the Company’s stockholders at the annual meeting of stockholders.  The Fourth Amended and Restated Investment Advisory Agreement, which is effective beginning as of May 3, 2017, (i) reduced the base management fee from an annual rate of 1.75% to an annual rate of 1.50% of the Company’s gross assets, excluding cash and cash equivalents but including assets purchased with borrowed funds, payable quarterly in arrears and (ii) reduced the hurdle rate for the income component of the incentive fee from 2.00% per quarter (8.00% annualized) to 1.75% per quarter (7.00% annualized).

Earnings Conference Call

We will host an earnings conference call at 10:00 a.m. (Eastern Time) on Thursday, May 11, 2017 to discuss our first quarter financial results. All interested parties are welcome to participate. The conference call can be accessed at the following dial-in number: (888) 588-0798. International callers can access the conference call by dialing (706) 634-6548. All participants will need to enter the Conference ID 12913911.  All participants are asked to dial-in to the conference call 10-15 minutes prior to the call so that name and company information can be collected. 

During the earnings conference call, the Company intends to refer to the Q1 2017 Garrison Capital Inc. Earnings Presentation, which will be available prior to the conference call on the Investor Relations section of the Company’s website ( www.garrisoncapitalbdc.com ) under Webcasts & Presentations.

An archived replay of the call will be available within two hours after the call until 11:59 p.m. (Eastern Time) on   June 11, 2017. To hear the replay, please dial (855) 859-2056. International callers, please dial (404) 537-3406. For all replays, please enter the Conference ID 12913911.

ABOUT GARRISON CAPITAL INC.

Garrison Capital Inc. is a business development company that primarily invests in loans to U.S. based middle-market companies. The Company’s investment activities are managed by its investment adviser, Garrison Capital Advisers LLC, an affiliate of Garrison Investment Group LP (“Garrison Investment Group”). For more information, go to http://www.garrisoncapitalbdc.com .

ABOUT GARRISON INVESTMENT GROUP

Garrison Investment Group is an alternative investment and asset management firm founded in March 2007. Garrison Investment Group invests opportunistically in the debt of middle-market companies, primarily in the areas of corporate finance, real estate finance and structured finance. For more information, go to http://www.garrisoninv.com .

FORWARD-LOOKING STATEMENTS

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those expressed or implied in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contact: Garrison Capital Inc. Brian Chase www.garrisoncapitalbdc.com (212) 372-9590

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 250

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 254

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 353

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 155

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 143

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 313

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Total Voting Rights: A Crucial Overview

Updated Category News Views 192

Insights into Total Voting Rights and Capital Octopus AIM VCT plc is a company that regularly updates its shareholders regarding vital information, including total voting rights and capital structure. Current Share Capital Details As of the latest disclosure period, Octopus AIM VCT plc has an issued share capital comprising 223,655,160 Ordinary shares, each valued at 1...

Continue Reading
Understanding Market Sentiment for Bio-Techne's Stock

Updated Category News Views 130

Analyzing Bio-Techne's Market Position Bio-Techne (NYSE: TECH) has recently seen an increase in the short percent of float, now standing at 29.12% since its last report. This translates to approximately 5.08 million shares sold short, making up 3.68% of all available regular shares for trading. With the current trading volume, it would typically take about 2.66 days for...

Continue Reading
Innovative Developments in Wound Care by Kane Biotech Inc.

Updated Category News Views 120

Advancements in Wound Care from Kane Biotech Inc. WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is making headlines with groundbreaking clinical and scientific advancements in wound care. The company recently showcased its innovative data during the Innovations in Wound Healing Annual Meeting, an event dedicated to revolutionizing treatment in this critical field....

Continue Reading
Senior Helpers Achieves Recognition as a Leading Franchise

Updated Category News Views 178

Senior Helpers Achieves Recognition as a Leading Franchise Independent Survey Shows Franchise Owners Are Highly Satisfied with Senior Helpers' Support and Overall Performance Senior Helpers has recently been awarded the title of a Top Franchise for 2025 by Franchise Business Review (FBR). This year marks a significant milestone as it is FBR's 20th year of recognizing...

Continue Reading
Bearish Moves: What Big Players Think of Super Micro Computer

Updated Category News Views 232

Diving into Super Micro Computer's Options Landscape You gotta love this market, right? Sometimes it’s a real gut check, and right now, Super Micro Computer (NASDAQ:SMCI) is at the forefront of some, let’s say, interesting options activity. Financial giants are making bearish moves—like, big-time bearish. Our look into the options history for good ol' SMCI shook out...

Continue Reading